Advertisement
CNO or JXN or MET
Which Stock Would AI Choose? CNO Financial Group (CNO) vs. Jackson Financial (JXN) vs. MetLife (MET) Stock Comparison
Key Takeaways
- Jackson Financial (JXN) leads year-to-date (YTD) performance with +8% gains, outpacing CNO (+5.5%) and MET (+2.4%).
- CNO delivered a strong Q1 2026 earnings beat, with operating earnings per share (EPS) up 33% to $1.05 and new annualized premiums (NAP) rising 11%.
- MET boosted its quarterly dividend by 4.4%, signaling confidence amid stable global operations, while JXN expanded share repurchases.
- All three exhibit resilient price-to-earnings (P/E) ratios around 15-17, with JXN offering the highest dividend yield at 3.15%.
- Insurance sector tailwinds support momentum, but JXN's higher beta (1.40) indicates greater volatility versus MET (0.77).
Introduction
In the competitive life and health insurance sector, CNO, JXN, and MET offer distinct profiles for investors seeking exposure to annuities, supplemental coverage, and retirement solutions. This comparison highlights their relative performance amid shifting interest rates and economic signals in recent market activity. Traders focused on sector rotation or value plays, and long-term investors eyeing dividend stability, will find value in evaluating business models, momentum, and risk factors across these mid- to large-cap names.
CNO Overview and Recent Performance
CNO Financial Group specializes in insurance products like Medicare supplements, annuities, and life coverage targeted at middle-income pre-retirees in the U.S. With a market capitalization of approximately $4.2 billion, the stock trades near its 52-week high around $44.60, reflecting +5.5% YTD gains and a low beta of 0.83 for relative stability. Recent weeks have been bolstered by robust Q1 2026 results, including 33% growth in operating EPS to $1.05 and 8.5% revenue increase, driven by 11% higher NAP and strong sales across segments. Positive net investment income and controlled expenses have enhanced sentiment, though shares remain sensitive to interest rate fluctuations impacting annuities.
JXN Overview and Recent Performance
Jackson Financial (JXN) focuses on annuities, institutional products, and closed life blocks, serving retail and institutional clients primarily in the U.S. Its $8 billion market cap underscores a niche in retirement income solutions. Shares hover near $114, delivering the strongest YTD return at +8% amid broader sector gains, though with higher beta (1.40) signaling volatility. Recent market activity features an expanded $1 billion share repurchase program and upcoming Q1 earnings on May 5, 2026. Solid liquidity with $5.7 billion in cash supports capital returns via a 3.15% dividend yield, fostering positive investor positioning despite thin recent profit margins.
MET Overview and Recent Performance
MetLife (MET), a global leader in insurance and employee benefits, operates across group benefits, Asia, Latin America, and more, with a massive $52 billion market capitalization. Shares trade around $80, up +2.4% YTD, supported by a defensive beta of 0.77. In recent weeks, a 4.4% quarterly dividend hike to $0.593 per share has driven gains, ahead of Q1 earnings expected May 5, 2026, with EPS forecasts at $2.23. Diversified revenue streams and strong cash reserves mitigate risks, though high debt-to-equity (226%) warrants monitoring amid rate sensitivity.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of 25 top-performing AI trading bots from its library of over 350, tailored to current market conditions across sectors like finance, semiconductors, and ETFs. These bots employ diverse strategies—trend following, dip buying, volatility plays—with impressive stats: annualized returns ranging from +23% to +163%, win rates of 51-88%, profit factors up to 11.7, and average trade durations from 1 day to 49 days. Risk management via take-profit/stop-loss corridors (e.g., 3%/2%) is standard, enabling copy trading on thousands of tickers. While none currently spotlight CNO, JXN, or MET, the platform’s AI scans for optimal fits. Traders seeking automated, data-driven edges should explore these trending options for potential alignment with insurance sector momentum.
Head-to-Head Comparison
CNO, JXN, and MET all thrive in life/health insurance but differ in scale and focus: CNO targets U.S. middle-market individuals, JXN emphasizes U.S. annuities with institutional exposure, and MET provides global diversification. Growth drivers include CNO’s NAP momentum, JXN’s buybacks, and MET’s international benefits. Recent momentum favors JXN’s YTD lead, contrasting MET’s steadier path. Risk profiles vary—JXN’s elevated beta versus MET’s lower volatility—with all facing interest rate and regulatory pressures. Valuation sensitivity is balanced at similar P/E ratios (~15-17), but JXN’s lower price-to-book (0.85) and higher yield appeal to value seekers, while MET’s size offers liquidity trade-offs.
Tickeron AI Verdict
Tickeron’s AI analysis would likely lean toward JXN in the current environment, given its superior YTD momentum, attractive valuation metrics, and capital return catalysts like repurchases—positioning it for potential outperformance if sector trends persist. However, CNO’s earnings stability and MET’s defensive scale provide probabilistic hedges, particularly around upcoming Q1 reports. Relative strength favors monitoring JXN’s volatility for entry points.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNO’s FA Score shows that 2 FA rating(s) are green whileJXN’s FA Score has 1 green FA rating(s), and MET’s FA Score reflects 0 green FA rating(s).
- CNO’s FA Score: 2 green, 3 red.
- JXN’s FA Score: 1 green, 4 red.
- MET’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNO’s TA Score shows that 3 TA indicator(s) are bullish while JXN’s TA Score has 4 bullish TA indicator(s), and MET’s TA Score reflects 5 bullish TA indicator(s).
- CNO’s TA Score: 3 bullish, 3 bearish.
- JXN’s TA Score: 4 bullish, 6 bearish.
- MET’s TA Score: 5 bullish, 4 bearish.
Price Growth
CNO (@Life/Health Insurance) experienced а +1.43% price change this week, while JXN (@Life/Health Insurance) price change was +0.56% , and MET (@Life/Health Insurance) price fluctuated -0.82% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.11%. For the same industry, the average monthly price growth was +2.25%, and the average quarterly price growth was +6.59%.
Reported Earning Dates
CNO is expected to report earnings on Aug 03, 2026.
JXN is expected to report earnings on Aug 11, 2026.
MET is expected to report earnings on Aug 05, 2026.
Industries' Descriptions
@Life/Health Insurance (+0.11% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| CNO | JXN | MET | |
| Capitalization | 4.31B | 7.61B | 50.6B |
| EBITDA | N/A | N/A | N/A |
| Gain YTD | 9.163 | 3.165 | 1.101 |
| P/E Ratio | 18.62 | 15.31 | 15.21 |
| Revenue | 4.51B | 5.7B | 76B |
| Total Cash | 9.11B | 54.1B | N/A |
| Total Debt | 4.3B | 4.57B | 20.2B |
CNO | MET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 25 | 13 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 41 Fair valued | |
PROFIT vs RISK RATING 1..100 | 18 | 48 | |
SMR RATING 1..100 | 94 | 99 | |
PRICE GROWTH RATING 1..100 | 47 | 53 | |
P/E GROWTH RATING 1..100 | 21 | 34 | |
SEASONALITY SCORE 1..100 | 75 | 47 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (41) in the Life Or Health Insurance industry is in the same range as CNO (68). This means that MET’s stock grew similarly to CNO’s over the last 12 months.
CNO's Profit vs Risk Rating (18) in the Life Or Health Insurance industry is in the same range as MET (48). This means that CNO’s stock grew similarly to MET’s over the last 12 months.
CNO's SMR Rating (94) in the Life Or Health Insurance industry is in the same range as MET (99). This means that CNO’s stock grew similarly to MET’s over the last 12 months.
CNO's Price Growth Rating (47) in the Life Or Health Insurance industry is in the same range as MET (53). This means that CNO’s stock grew similarly to MET’s over the last 12 months.
CNO's P/E Growth Rating (21) in the Life Or Health Insurance industry is in the same range as MET (34). This means that CNO’s stock grew similarly to MET’s over the last 12 months.
| CNO | JXN | MET | |
|---|---|---|---|
| RSI ODDS (%) | 2 days ago 74% | 2 days ago 60% | 1 day ago 67% |
| Stochastic ODDS (%) | N/A | 2 days ago 71% | 1 day ago 59% |
| Momentum ODDS (%) | N/A | 2 days ago 62% | N/A |
| MACD ODDS (%) | N/A | 2 days ago 68% | 1 day ago 61% |
| TrendWeek ODDS (%) | 2 days ago 59% | 2 days ago 64% | 1 day ago 59% |
| TrendMonth ODDS (%) | 2 days ago 58% | 2 days ago 79% | 1 day ago 48% |
| Advances ODDS (%) | 5 days ago 60% | 15 days ago 77% | 7 days ago 61% |
| Declines ODDS (%) | 21 days ago 51% | 8 days ago 64% | 2 days ago 56% |
| BollingerBands ODDS (%) | 2 days ago 68% | 2 days ago 71% | 1 day ago 76% |
| Aroon ODDS (%) | 2 days ago 52% | 2 days ago 75% | 1 day ago 45% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| FOREX / NAME | Price $ | Chg $ | Chg % |
| EURAUD | 1.68 | 0.05 | +3.12% |
| Euro - Australian Dollar | |||
| CHFAUD | 1.82 | 0.04 | +2.47% |
| Switzerland Franc - Australian Dollar | |||
| JPYAUD | 0.01 | 0.00 | +2.07% |
| Japan Yen - Australian Dollar | |||
| USDCNY | 6.91 | N/A | N/A |
| United States Dollar - China Yuan | |||
| AUDCAD | 0.96 | -0.03 | -3.48% |
| Australian Dollar - Canadian Dollar | |||
CNO and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNO has been closely correlated with JXN. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if CNO jumps, then JXN could also see price increases.
JXN and
Correlation & Price change
A.I.dvisor indicates that over the last year, JXN has been closely correlated with CNO. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if JXN jumps, then CNO could also see price increases.